Clinical trial
Immunogenicity of an Inactivated COVID-19 Vaccine for Prevention of COVID-19 in Population Aged 3-11 Years
NCT05198336 is registered in ClinicalTrials.gov with Sinovac Research and Development Co., Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Immunogenicity of an Inactivated COVID-19 Vaccine for Prevention of COVID-19 in Population Aged 3-11 Years
- Lead sponsor
- Sinovac Research and Development Co., Ltd.
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- January 8, 2022
- Completion date
- December 30, 2022
- Enrollment
- 395 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.